Dr. Lal PathLabs (NSE:LALPATHLAB) PB Ratio : 10.63 (As of May. 01, 2025)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-05-01), Dr. Lal PathLabs's share price is ₹2769.10. Dr. Lal PathLabs's Book Value per Share for the quarter that ended in Mar. 2025 was ₹260.62. Hence, Dr. Lal PathLabs's PB Ratio of today is 10.63.

Good Sign:

Dr. Lal PathLabs Ltd stock PB Ratio (=10.66) is close to 2-year low of 9.65.

The historical rank and industry rank for Dr. Lal PathLabs's PB Ratio or its related term are showing as below:

NSE:LALPATHLAB' s PB Ratio Range Over the Past 10 Years
Min: 7.94 Med: 12.42 Max: 22.55
Current: 10.66

During the past 13 years, Dr. Lal PathLabs's highest PB Ratio was 22.55. The lowest was 7.94. And the median was 12.42.

NSE:LALPATHLAB's PB Ratio is ranked worse than
92.65% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.99 vs NSE:LALPATHLAB: 10.66

During the past 12 months, Dr. Lal PathLabs's average Book Value Per Share Growth Rate was 17.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 15.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 19.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dr. Lal PathLabs was 43.60% per year. The lowest was 12.70% per year. And the median was 23.10% per year.

Back to Basics: PB Ratio

Dr. Lal PathLabs PB Ratio Historical Data

The historical data trend for Dr. Lal PathLabs's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs PB Ratio Chart

Dr. Lal PathLabs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

PB Ratio

Get a 7-Day Free Trial

18.12

14.33

9.10

10.18

9.51

Dr. Lal PathLabs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
PB Ratio	Get a 7-Day Free Trial															10.18	-	13.74	-	9.51

Competitive Comparison of Dr. Lal PathLabs's PB Ratio

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Lal PathLabs's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's PB Ratio falls into.

Save Embed

;

Save Embed

;

Dr. Lal PathLabs PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Dr. Lal PathLabs's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2025)
	=	2769.10	/	260.619
	=	10.63

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Dr. Lal PathLabs (NSE:LALPATHLAB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Dr. Lal PathLabs PB Ratio Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

539524:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines